Teva has long called Pennsylvania its U.S. home base, but a newly approved tax incentive plan indicates that New Jersey may just be trying to woo it away.
The New Jersey Economic Development Authority has approved a 10-year, $40 million package to make a case for a relocation to Parsippany, New Jersey, Biz reported.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,